Status of and prospects for bronchoscopic lung volume reduction for patients with severe emphysema

Yu, Hang; Wang, Lijie; Wu, Zhen; Yang, Zhen

doi:10.5582/bst.2016.01113

Cited by 2 publications

(2 citation statements)

References 80 publications

(97 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even though the decrease in the anxiety scale scores during evaluations before and after the procedure was not reflected in the statistics, a statistically significant decrease was observed in depression scores. e positive impact of the coil procedure on the lungs is shrinking the damaged emphysematous airways, thus reducing the lung volume leading to reduced hyperinflation and hence decreased dyspnea, decreased fast and surface respiration, reduction in airway resistance, and provision of air flow in healthy areas [26,27]. A decrease in both anxiety and depressive symptoms can be expected when the impacts of the procedure are considered on dyspnea and related factors thought to be factors of COPD and mental comorbidity.…”

Section: Discussionmentioning

confidence: 99%

Impacts of Coil Treatment on Anxiety and Depression in Emphysema

Uğurlu

2020

Canadian Respiratory Journal

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a widespread, preventable, and treatable disease. Emphysema is one of the primary components of COPD and manifests itself via decrease in elastic recoil, hyperinflation, and increase in air trapping. Various lung-volume-reduction treatments have come up in recent years for late-stage emphysema patients. Mental disorders and especially anxiety and depression are among the frequently encountered comorbid cases observed in COPD. The aim of our study was to examine the impact of coil treatment applied for late-stage COPD-emphysema diagnosed patients on the accompanying anxiety and depressive symptoms. A total of 21 patients diagnosed with emphysema that meet the suitability criteria for coil treatment were included in the study. The accompanying anxiety and depressive symptoms of the patients were assessed via beck anxiety inventory (BAI) and beck depression inventories (BDI-I) prior to the procedure and one month later. All patients were male with an age average of 66.5 ± 5.5 (57–76). Among patients without a psychiatric diagnosis, BAI scores before and after coil treatment were determined, respectively, as 12.1 ± 6.3 (4–26) and 11.2 ± 9.3 (0–28), whereas BDI-I scores before and after coil treatment were determined, respectively, as 13.5 ± 10.4 (1–31) and 8.8 ± 10.6 (0–34), with a statistically significant difference between them. Also among patients with a psychiatric diagnosis, both anxiety and depressive symptoms decreased after coil treatment, and this reduction was found more significant for anxiety. Coil treatment as a current and novel treatment method for COPD-emphysema diagnosed patients with or without psychiatric comorbidity has a positive impact on anxiety and depressive symptoms.

show abstract

Section: Discussionmentioning

confidence: 99%

Impacts of Coil Treatment on Anxiety and Depression in Emphysema

Uğurlu

2020

Canadian Respiratory Journal

View full text Add to dashboard Cite

show abstract

“…41 Yu et al performed all volume reduction procedures to the upper lobe. 42 In our study, we performed EBV on 18 patients (58.1%) to the right upper lobe and 8 patients (25.8%) to the left upper lobe. In the EBC patients, we performed the EBC to mostly 22 patients (75.85%) to the right upper lobe and 4 patients (13.80%) to the left lower lobe.…”

Section: Endobronchialmentioning

confidence: 99%

Endobronchial valve vs coil for lung volume reduction in emphysema: results from a tertiary care centre in Turkey

2020

View full text Add to dashboard Cite

BACKGROUND: Bronchoscopic lung volume reduction (BLVR) by either the endobronchial valve (EBV) or coil (EBC) procedure is recommended for severe emphysematous patients. BLVR applications generally help healthy lung areas ventilate more comfortably by reducing the hyperinflation and improving the contraction capacity of diaphragm. OBJECTIVES: Compare our experience with valve and coil BLVR devices. DESIGN: Retrospective. SETTING: Single tertiary care centre. PATIENTS AND METHODS: Demographic data, vital signs, pulmonary function tests (PFTs), the six-minute walking test (6MWT), vital signs, arterial blood gases and complications were recorded. MAIN OUTCOME MEASURES: Change in PFTs and completion of the 6MWT. SAMPLE SIZE: 60 Turkish men with a diagnosis of chronic pulmonary lung disease. RESULTS: Clinical and demographic characteristics were similar in patients who underwent EBV and EBC. Thirty (96.8%) EBV patients and 27 (93.1%) of the EBC patients were able to properly complete the PFT before the procedures, but all complied after the procedures. Significant improvement in PFTs were achieved after the procedure and there were no statistically significant differences in post-procedure performance. For the 6MWT, the completion rate improved from 15 (48.4%) to 19 (61.3%) patients in the EBV patients ( P =.125) and from 19 (65.5%) to 21 (72.4%) patients in the EBC patients ( P =.500). There was no significant difference in completion rates for the walking test for either group (median 32 meters in EBV patients and 37 meters in EBC patients; P =.652). Vital signs and arterial blood gases were similar in the two groups. The rates of complications were similar in both groups. CONCLUSION: Endobronchial valves and coils are safe and effective methods for BLVR for patients with severe emphysema. LIMITATIONS: Relatively small sample, retrospective design, single-centre retrospective study. CONFLICT OF INTEREST: None.

show abstract

Status of and prospects for bronchoscopic lung volume reduction for patients with severe emphysema

Cited by 2 publications

References 80 publications

Impacts of Coil Treatment on Anxiety and Depression in Emphysema

Impacts of Coil Treatment on Anxiety and Depression in Emphysema

Endobronchial valve vs coil for lung volume reduction in emphysema: results from a tertiary care centre in Turkey

Contact Info

Product

Resources

About